Cathie's Ark Logo
undefined Logo

ARKK Holdings of Beam Therapeutics (BEAM) - Updated Daily

TherapeuticsGene TherapyGenomicsGene Base Editing
Maxinomics Icon
Manufacturing is Coming Back to the US 🏗️
Date
Direction
Shares
Fund Weight
Fund
February 13, 2024
BUY10.191k0.0036%ARKK
February 8, 2024
BUY10.541k0.0037%ARKK
November 13, 2023
BUY39.569k0.0118%ARKK
October 27, 2023
BUY105.793k0.0335%ARKK
October 23, 2023
BUY1.372k0.0004%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
2.61%$2.92b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
15🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
14
🎫ARK Ownership Percent
7.22%

Other ETFs That Hold BEAM

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.87%
GNOMGlobal X Genomics & Biotechnology ETF3.11%
ARKKARK Innovation ETF2.92%
XBISPDR® S&P Biotech ETF0.94%
IBBiShares Biotechnology ETF0.22%
LABUS&P Biotech Bull 3X Shares ETF0.204%

Research Notes and Commentary for BEAM

No Research Notes Found for BEAM